Further analysis showed elevated CD4+ and CD8+ T cell ratios in the tumor, as well as in the spleen after OxP or OxP+PD-L1 trap treatment in both models (Fig. 6c–f), and confirmed the effect of OxP in promoting anti-tumor responses. The gene discussed is CD274; the disease is neoplasm.